Header Logo

Connection

Ross Abrams to Survival Rate

Back to Details
This is a "connection" page, showing publications Ross Abrams has written about Survival Rate.
Ross Abrams
Connection Strength
0.422
Survival Rate
  1. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg. 2007 Mar; 142(3):285-8.
    View in: PubMed
    Score: 0.065
  2. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997 Sep; 226(3):248-57; discussion 257-60.
    View in: PubMed
    Score: 0.034
  3. Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation. Radiology. 1997 Jun; 203(3):865-70.
    View in: PubMed
    Score: 0.033
  4. Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer. Br J Cancer. 2017 May 09; 116(10):1264-1270.
    View in: PubMed
    Score: 0.033
  5. The clinical use of multimodality therapy in the management of cancer. In Vivo. 1994 Nov-Dec; 8(5):635-42.
    View in: PubMed
    Score: 0.028
  6. Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 =90 U/mL and comparison to the CONKO-001 trial. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):e291-7.
    View in: PubMed
    Score: 0.023
  7. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol. 2011 May; 18(5):1319-26.
    View in: PubMed
    Score: 0.021
  8. A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation. Ann Surg. 2011 Feb; 253(2):328-35.
    View in: PubMed
    Score: 0.021
  9. Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol. 2011 Feb; 18(2):337-44.
    View in: PubMed
    Score: 0.021
  10. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival. J Gastrointest Surg. 2005 Dec; 9(9):1191-204; discussion 1204-6.
    View in: PubMed
    Score: 0.015
  11. Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610. J Clin Oncol. 2003 Apr 01; 21(7):1238-48.
    View in: PubMed
    Score: 0.012
  12. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg. 2003 Jan; 7(1):1-9; discussion 9-11.
    View in: PubMed
    Score: 0.012
  13. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002 Sep; 236(3):355-66; discussion 366-8.
    View in: PubMed
    Score: 0.012
  14. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2001 Dec; 7(12):4115-21.
    View in: PubMed
    Score: 0.011
  15. Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma. Biol Blood Marrow Transplant. 2001; 7(10):561-7.
    View in: PubMed
    Score: 0.011
  16. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies. Bone Marrow Transplant. 1998 Nov; 22(10):947-55.
    View in: PubMed
    Score: 0.009
  17. Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg. 1998 May-Jun; 2(3):207-16.
    View in: PubMed
    Score: 0.009
  18. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg. 1997 May; 225(5):621-33; discussion 633-6.
    View in: PubMed
    Score: 0.008
  19. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996 Oct; 224(4):463-73; discussion 473-5.
    View in: PubMed
    Score: 0.008
  20. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996 Jun; 223(6):718-25; discussion 725-8.
    View in: PubMed
    Score: 0.008
  21. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol. 1996 Feb; 14(2):556-64.
    View in: PubMed
    Score: 0.008
  22. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys. 1995 Jun 15; 32(3):567-76.
    View in: PubMed
    Score: 0.007
  23. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg. 1995 Jun; 221(6):788-97; discussion 797-8.
    View in: PubMed
    Score: 0.007
  24. Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease. J Clin Oncol. 1993 Apr; 11(4):698-703.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.